Regulators and empowered consumers are placing tremendous pressure on pharmaceutical companies to meet increasingly stringent drug quality and safety requirements while demonstrating the superiority of their therapies over a growing number of generic alternatives.
Your firms have a wealth of knowledge locked in the massive amounts of data gathered throughout the discovery-to-commercialization process that can help meet these demands. The challenge, however, lies in being able to uncover key insights from this complex data to help produce high quality and effective therapies faster and at lower costs.
Ayasdi Cure™ can help. It fundamentally changes the way data is analyzed and uncovers knowledge from highly complex and disparate data sets. Relying on advanced algorithms and machine learning, it can quickly discover and visualize critical intelligence that was previously hidden or overlooked. These insights can help your firms expedite biomarker discovery, prevent costly late-stage failures, detect adverse events early, and enable precision medicine.